Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 42
Filtrar
2.
An. bras. dermatol ; 97(6): 747-756, Nov.-Dec. 2022. tab, graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1403184

RESUMO

Abstract Background: Vulvar diseases are common in the general population and have a negative impact on the quality of life. Objectives: To describe our experience as dermatologists in the management of vulvar dermatosis consultations. Methods: A retrospective observational study was conducted with patients who attended monographic vulvar consultations over a 5-year period. Clinical information was obtained from the patient's charts. Results: 148 women were studied. Their mean age was 43.24 years (standard deviation: 15.15 years), with ages ranging from 4 months to 80 years. 53.4% of patients took between 2 and 5 years to seek medical attention for the first time. The most frequent diagnosis was lichen sclerosus (41.9%), irritative eczema of the vulva (14.9%), and lichen simplex chronicus (10.1%). 83.8% reported anogenital itching, 66.2% pain, and 45.9% dyspareunia. The most frequently prescribed treatment was ultra-potent topical corticosteroids (clobetasol propionate; 41.2%). Patients with lichen sclerosus were significantly older than those who presented with any of the other diseases. No differences were found in terms of either the time of disease evolution or in symptom presentation. Study limitations: Retrospective study. Vulvar diseases with an infectious cause are usually managed in primary care, therefore, were not included. All patients were recruited from a single private hospital which limits the comparisons with the public health system. Conclusions: Vulvar diseases frequently occur and are associated with high morbidity. It is essential to promote the development of specific vulvar consultations in hospitals. Specialties such as dermatology, gynecology, urology, or physiotherapy must be part of these units.

3.
An Bras Dermatol ; 97(6): 747-756, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36089549

RESUMO

BACKGROUND: Vulvar diseases are common in the general population and have a negative impact on the quality of life. OBJECTIVES: To describe our experience as dermatologists in the management of vulvar dermatosis consultations. METHODS: A retrospective observational study was conducted with patients who attended monographic vulvar consultations over a 5-year period. Clinical information was obtained from the patient's charts. RESULTS: 148 women were studied. Their mean age was 43.24 years (standard deviation: 15.15 years), with ages ranging from 4 months to 80 years. 53.4% of patients took between 2 and 5 years to seek medical attention for the first time. The most frequent diagnosis was lichen sclerosus (41.9%), irritative eczema of the vulva (14.9%), and lichen simplex chronicus (10.1%). 83.8% reported anogenital itching, 66.2% pain, and 45.9% dyspareunia. The most frequently prescribed treatment was ultra-potent topical corticosteroids (clobetasol propionate; 41.2%). Patients with lichen sclerosus were significantly older than those who presented with any of the other diseases. No differences were found in terms of either the time of disease evolution or in symptom presentation. STUDY LIMITATIONS: Retrospective study. Vulvar diseases with an infectious cause are usually managed in primary care, therefore, were not included. All patients were recruited from a single private hospital which limits the comparisons with the public health system. CONCLUSIONS: Vulvar diseases frequently occur and are associated with high morbidity. It is essential to promote the development of specific vulvar consultations in hospitals. Specialties such as dermatology, gynecology, urology, or physiotherapy must be part of these units.


Assuntos
Líquen Escleroso e Atrófico , Doenças da Vulva , Líquen Escleroso Vulvar , Adulto , Clobetasol/uso terapêutico , Estudos Transversais , Feminino , Glucocorticoides/uso terapêutico , Humanos , Líquen Escleroso e Atrófico/tratamento farmacológico , Qualidade de Vida , Estudos Retrospectivos , Vulva , Doenças da Vulva/diagnóstico , Doenças da Vulva/tratamento farmacológico , Líquen Escleroso Vulvar/diagnóstico , Líquen Escleroso Vulvar/tratamento farmacológico
5.
Int J Dermatol ; 60(10): 1248-1252, 2021 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-33846978

RESUMO

BACKGROUND: Digital clubbing is a well-known clinical sign characterized by thickening of the distal phalanges of the fingers and toes. Unilateral clubbing occurs less frequently. A previous report showed for the first time two cases of unilateral clubbing as a clinical manifestation of lower limb venous malformation. The objective of the present study is to describe a series of 13 patients with a low-flow vascular malformation where a clubbing-like unilateral digital thickening is also observed. METHODS: All patients were retrospectively included after reviewing clinical photographs from a vascular malformations database. RESULTS: A total of 13 patients with low-flow vascular malformations were included in this study. The mean age at diagnosis was 11 years (range 5-26 years) with a female predominance (nine patients). The most frequent vascular malformation collected was a blue rubber bleb nevus syndrome in four patients, followed by common venous malformations in three patients. All patients characteristically exhibited a clubbing-like digital thickening. Seven patients had foot involvement and six patients hand involvement. CONCLUSIONS: Although the number of cases is limited, our study is the first series of cases where a clubbing-like digital thickening is described in patients with a low-flow vascular malformation. The unilateral presence of clubbing or pseudoclubbing should lead to the suspicion of an underlying vascular malformation.


Assuntos
Nevo Azul , Osteoartropatia Hipertrófica Secundária , Neoplasias Cutâneas , Malformações Vasculares , Adolescente , Adulto , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Estudos Retrospectivos , Malformações Vasculares/diagnóstico , Malformações Vasculares/diagnóstico por imagem , Adulto Jovem
7.
Med. clín (Ed. impr.) ; 156(6): 314-314, marzo 2021. ilus
Artigo em Inglês | IBECS | ID: ibc-208486
9.
Int J Dermatol ; 60(7): 844-850, 2021 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-33570165

RESUMO

BACKGROUND: Melanoma mortality rates are stabilizing and in certain regions and age groups are trending down. Although there are some studies that predict melanoma mortality in other countries, there are currently no studies that predict mortality in Spain in the coming years. The main aim of this study is to calculate melanoma mortality projections in Spain for the period 2019-2043. METHODS: This is a population-based ecological study that utilized information from the Spanish National Statistics Institute. Analysis included deaths as a result of cutaneous melanoma in Spain in the period 1979-2018, and data was analyzed according to gender and age group. Projections were made until 2043 in five-year periods, calculated in Nordpred (within the R software). RESULTS: Our estimates predict that in the period 2019-2043, there will be 30,477.9 deaths from melanoma in Spain, with the age group of >85 years being the group with the highest number of deaths. The expected average annual death rate for melanoma in both genders for the period 2019-2043 is 1,269.9 deaths / year. The predicted age-standardized mortality rates varied between 4.62/100.000 inhabitants in the 2019-2023 period and 3.94/100.000 inhabitants in the 2039-2043 period. CONCLUSIONS: Overall mortality rate and age-standardized melanoma death rates in older people of both genders will increase in the coming years in Spain, while rates in younger people will stabilize or decrease progressively. In the coming years, prevention efforts should focus on the young, but the emphasis should also be on educating the elderly in early detection of melanoma.


Assuntos
Melanoma , Neoplasias Cutâneas , Idoso , Idoso de 80 Anos ou mais , Feminino , Previsões , Humanos , Masculino , Espanha/epidemiologia
12.
JMIR Dermatol ; 4(1): e21709, 2021 Jun 08.
Artigo em Inglês | MEDLINE | ID: mdl-37625163
14.
Int J Dermatol ; 60(1): 93-98, 2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-32530054

RESUMO

BACKGROUND: Cutaneous carcinosarcoma is a rare biphasic tumor comprising malignant epithelial and heterologous mesenchymal elements. Data on the clinical and histopathologic characteristics of this tumor are scarce. The objective of this study was to describe the clinicopathologic and immunohistochemical features of cutaneous carcinosarcoma. METHODS: A descriptive retrospective study was conducted in a tertiary care hospital from Spain. We reviewed the records of eight patients with cutaneous carcinosarcoma who were diagnosed from 2009 to 2019. RESULTS: The mean patient age at diagnosis was 72.13 years (range 44-91 years), and there was a male predilection (6 cases). The most common site of cutaneous carcinosarcoma was the head and neck (5 cases). Carcinosarcomas demonstrated variable histopathological and immunohistochemical features. Follow-up was available for 7-8 patients. There were two cases of local recurrence and one case of metastasis. Two patients died from the tumor during the entire follow-up. CONCLUSIONS: Although the number of cases in this study was limited, our results provide valuable insight into the clinical, histopathologic, and immunohistochemical characteristics of primary cutaneous carcinosarcoma.


Assuntos
Carcinossarcoma/metabolismo , Carcinossarcoma/patologia , Recidiva Local de Neoplasia/patologia , Neoplasias Cutâneas/metabolismo , Neoplasias Cutâneas/patologia , Actinas/metabolismo , Adulto , Idoso de 80 Anos ou mais , Antígenos CD/metabolismo , Antígenos de Diferenciação Mielomonocítica/metabolismo , Carcinossarcoma/secundário , Carcinossarcoma/cirurgia , Desmina/metabolismo , Feminino , Humanos , Imuno-Histoquímica , Queratina-1/metabolismo , Queratina-3/metabolismo , Masculino , Proteínas de Ligação à Região de Interação com a Matriz/metabolismo , Proteínas de Membrana/metabolismo , Pessoa de Meia-Idade , Miogenina/metabolismo , Neprilisina/metabolismo , Estudos Retrospectivos , Neoplasias Cutâneas/cirurgia , Fatores de Transcrição/metabolismo , alfa 1-Antitripsina/metabolismo
16.
Dermatol Ther ; 34(1): e14658, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-33301207

RESUMO

The term craniofacial hyperhidrosis (HH) refers to HH that affects the face and/or scalp. Few studies have focused on this specific location, and even fewer distinguish between the two areas. Our study aims are to describe the clinical characteristics of patients with craniofacial HH, specifying whether the condition affects the scalp, face or both, and to compare these cases with those recorded at other locations. As secondary objectives, we determine the effectiveness and adverse effects of oral oxybutynin (OOx), and assess patients' adherence to treatment. This prospective observational study was carried out with respect to the period 2007-2019. All patients diagnosed with HH of the scalp and/or face and who were treated with OOx at our HH unit were included in the study group. Of 292 patients treated with OOx, 97 (33.2%) had craniofacial HH. Of these, 4 (4.1%) presented HH exclusively on the scalp, 56 (57.7%) exclusively on the face and 37 (38.1%) in both locations. The patients in the latter category (compared with those with exclusively facial HH) were significantly older than the others, had a later onset of HH, a greater frequency of secondary HH, less simultaneous involvement of the classical areas of primary focal HH (the palms, soles, and armpits) and greater generalized HH and of the trunk. No significant differences were observed between the three locations (face, scalp, or both) regarding the efficacy and side effects of OOx. The patients with exclusively facial HH presented greater adherence to treatment.


Assuntos
Hiperidrose , Ácidos Mandélicos , Axila , Humanos , Hiperidrose/diagnóstico , Hiperidrose/tratamento farmacológico , Ácidos Mandélicos/efeitos adversos , Estudos Prospectivos , Resultado do Tratamento
17.
Med Clin (Barc) ; 156(6): 314, 2021 03 26.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-32778430
19.
An. bras. dermatol ; 95(5): 670-671, Sept.-Oct. 2020. graf
Artigo em Inglês | LILACS, Coleciona SUS | ID: biblio-1130944
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...